Log In
Print
BCIQ
Print
Print this Print this
 

PT010

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCombination of glycopyrrolate (PT001), a long-acting muscarinic antagonist (LAMA), formoterol fumarate (PT005), a long-acting beta-2 agonist (LABA), and an inhaled corticosteroid (ICS) delivered via a single metered-dose hydrofluoroalkane (HFA) inhaler
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today